Medical
UV1 Cancer Vaccine Receives FDA Fast Track for Mesothelioma: 23-Month Survival Data Explained
David Foster
March 1, 2026
UV1 telomerase vaccine earned FDA Fast Track designation for mesothelioma. Learn about the NIPU trial's 23-month survival data and what it means for patients.
11 min read 8 FAQs
Read